Ankylosing spondylitis trials in Czechia

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  Where

  Brno, Brno-Židenice, Hlučín, Novy Hradec Kralove, Olomouc, Prague, Prague 1, Prague 11, Prague 2, Prague 4, Praha 4, Trebovice, Uherské Hradiště

  People

  339 worldwide

  Run by

  Novartis Pharma AG

  See details and how to joinNCT04638647 · EU 2023-504417-67-00
• Phase 1Taking people
  A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

  Where

  Brno, Hlučín, Ostrava, Uherské Hradiště

  Age

  18 years and over

  People

  392 worldwide

  Run by

  UCB Biopharma SRL

  See details and how to joinNCT07290036